Jun 23, 2013
New Market Report: Fougera Pharmaceuticals Inc. - Pharmaceuticals &...
Fougera is a subsidiary of Sandoz. The company manufactures topical pharmaceuticals products for dermatology market.
Sandoz Completes Acquisition of Generic Dermatology Company Fougera for $1.5 Billion
Sandoz announced it has completed the acquisition of Fougera Pharmaceuticals, a maker of generic dermatology products, for $1.525 billion in an all-cash transaction.
Drug Store News
Fougera names SVP commercial operations
Kaczmarek, who joined the company in 2004, has been managing national accounts for Fougera's three marketing divisions, including Fougera, PharmaDerm, and Savage Labs, for the past eight years.
CDC adds Veregen as therapeutic option
PharmaDerm, based here, has announced that its Veregen Ointment , a topical medication for the treatment of external genital and perianal warts, has been added as a new therapeutic option in the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines, PRNewswire reports.